Caveolin-1 is necessary for hepatic oxidative lipid metabolism: Evidence for crosstalk between caveolin-1 and bile acid signaling

Cell Reports

Volumn 4, Issue 2, 2013, Pages 238-247

  Fernández Rojo, Manuel A ^a,g   Gongora, Milena ^a   Fitzsimmons, Rebecca L ^a   Martel, Nick ^a   Martin, Sheree D ^b   Nixon, Susan J ^a   Brooks, Andrew J ^a   Ikonomopoulou, Maria P ^a   Martin, Sally ^a   Lo, Harriet P ^a   Myers, Stephen A ^a   Restall, Christina ^c   Ferguson, Charles ^a   Pilch, Paul F ^f   McGee, Sean L ^b   Anderson, Robin L ^c,d   Waters, Michael J ^a   Hancock, John F ^e   Grimmond, Sean M ^a   Muscat, George E O ^a   Parton, Robert G ^a   more..

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CAVEOLIN 1; FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ADAPTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALORIMETRY; CONTROLLED STUDY; DIET RESTRICTION; ELECTRON MICROSCOPY; EMBRYO; FATTY ACID METABOLISM; GENE EXPRESSION; GENETIC ANALYSIS; HOMEOSTASIS; KETOGENESIS; LIPID METABOLISM; LIVER CELL; LIVER METABOLISM; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

MAMMALIA; MUS;

ANIMALS; BILE ACIDS AND SALTS; CAVEOLIN 1; LIPID METABOLISM; LIVER; MICE; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION;

EID: 84880848107     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.06.017     Document Type: Article

References (36)

1. Asterholm I.W., Mundy D.I., Weng J., Anderson R.G., Scherer P.E. Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1. Cell Metab. 2012, 15:171-185.
2. Astudillo A.M., Pérez-Chacón G., Meana C., Balgoma D., Pol A., Del Pozo M.A., Balboa M.A., Balsinde J. Altered arachidonate distribution in macrophages from caveolin-1 null mice leading to reduced eicosanoid synthesis. J.Biol. Chem. 2011, 286:35299-35307.
3. Bastiani M., Liu L., Hill M.M., Jedrychowski M.P., Nixon S.J., Lo H.P., Abankwa D., Luetterforst R., Fernandez-Rojo M., Breen M.R., et al. MURC/Cavin-4 and cavin family members form tissue-specific caveolar complexes. J. Cell Biol. 2009, 185:1259-1273.
4. Bosch M., Marí M., Herms A., Fernández A., Fajardo A., Kassan A., Giralt A., Colell A., Balgoma D., Barbero E., et al. Caveolin-1 deficiency causes cholesterol-dependent mitochondrial dysfunction and apoptotic susceptibility. Curr. Biol. 2011, 21:681-686.
5. Burns K.A., Vanden Heuvel J.P. Modulation of PPAR activity via phosphorylation. Biochim. Biophys. Acta 2007, 1771:952-960.
6. Calvo M., Tebar F., Lopez-Iglesias C., Enrich C. Morphologic and functional characterization of caveolae in rat liver hepatocytes. Hepatology 2001, 33:1259-1269.
7. Chakravarthy M.V., Pan Z., Zhu Y., Tordjman K., Schneider J.G., Coleman T., Turk J., Semenkovich C.F. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab. 2005, 1:309-322.
8. Chakravarthy M.V., Lodhi I.J., Yin L., Malapaka R.R., Xu H.E., Turk J., Semenkovich C.F. Identification of a physiologically relevant endogenous ligand for PPARalpha in liver. Cell 2009, 138:476-488.
9. Curtis R., Geesaman B.J., DiStefano P.S. Ageing and metabolism: drug discovery opportunities. Nat. Rev. Drug Discov. 2005, 4:569-580.
10. Desvergne B., Michalik L., Wahli W. Transcriptional regulation of metabolism. Physiol. Rev. 2006, 86:465-514.
11. Drab M., Verkade P., Elger M., Kasper M., Lohn M., Lauterbach B., Menne J., Lindschau C., Mende F., Luft F.C., et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 2001, 293:2449-2452.
12. Fernández M.A., Albor C., Ingelmo-Torres M., Nixon S.J., Ferguson C., Kurzchalia T., Tebar F., Enrich C., Parton R.G., Pol A. Caveolin-1 is essential for liver regeneration. Science 2006, 313:1628-1632.
13. Fernández-Rojo M.A., Restall C., Ferguson C., Martel N., Martin S., Bosch M., Kassan A., Leong G.M., Martin S.D., McGee S.L., et al. Caveolin-1 orchestrates the balance between glucose and lipid-dependent energy metabolism: implications for liver regeneration. Hepatology 2012, 55:1574-1584.
14. Frank P.G., Pedraza A., Cohen D.E., Lisanti M.P. Adenovirus-mediated expression of caveolin-1 in mouse liver increases plasma high-density lipoprotein levels. Biochemistry 2001, 40:10892-10900.
15. Fujimoto Y., Onoduka J., Homma K.J., Yamaguchi S., Mori M., Higashi Y., Makita M., Kinoshita T., Noda J., Itabe H., Takanoa T. Long-chain fatty acids induce lipid droplet formation in a cultured human hepatocyte in a manner dependent of Acyl-CoA synthetase. Biol. Pharm. Bull. 2006, 29:2174-2180.
16. Garg A., Agarwal A.K. Caveolin-1: a new locus for human lipodystrophy. J.Clin. Endocrinol. Metab. 2008, 93:1183-1185.
17. Goodwin B., Jones S.A., Price R.R., Watson M.A., McKee D.D., Moore L.B., Galardi C., Wilson J.G., Lewis M.C., Roth M.E., et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell 2000, 6:517-526.
18. Hayashi Y.K., Matsuda C., Ogawa M., Goto K., Tominaga K., Mitsuhashi S., Park Y.E., Nonaka I., Hino-Fukuyo N., Haginoya K., et al. Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. J.Clin. Invest. 2009, 119:2623-2633.
19. Jump D.B. Fatty acid regulation of hepatic lipid metabolism. Curr. Opin. Clin. Nutr. Metab. Care 2011, 14:115-120.
20. Kong B., Wang L., Chiang J.Y., Zhang Y., Klaassen C.D., Guo G.L. Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice. Hepatology 2012, 56:1034-1043.
21. Liu L., Brown D., McKee M., Lebrasseur N.K., Yang D., Albrecht K.H., Ravid K., Pilch P.F. Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance. Cell Metab. 2008, 8:310-317.
22. Mandard S., Müller M., Kersten S. Peroxisome proliferator-activated receptor alpha target genes. Cell. Mol. Life Sci. 2004, 61:393-416.
23. Martin S., Parton R.G. Lipid droplets: a unified view of a dynamic organelle. Nat. Rev. Mol. Cell Biol. 2006, 7:373-378.
24. Mayoral R., Fernández-Martínez A., Roy R., Boscá L., Martín-Sanz P. Dispensability and dynamics of caveolin-1 during liver regeneration and in isolated hepatic cells. Hepatology 2007, 46:813-822.
25. Otsu K., Toya Y., Oshikawa J., Kurotani R., Yazawa T., Sato M., Yokoyama U., Umemura S., Minamisawa S., Okumura S., Ishikawa Y. Caveolin gene transfer improves glucose metabolism in diabetic mice. Am. J. Physiol. Cell Physiol. 2010, 298:C450-C456.
26. Parton R.G., Simons K. The multiple faces of caveolae. Nat. Rev. Mol. Cell Biol. 2007, 8:185-194.
27. Pilch P.F., Liu L. Fat caves: caveolae, lipid trafficking and lipid metabolism in adipocytes. Trends Endocrinol. Metab. 2011, 22:318-324.
28. Pineda Torra I., Claudel T., Duval C., Kosykh V., Fruchart J.C., Staels B. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor. Mol. Endocrinol. 2003, 17:259-272.
29. Prade E., Tobiasch M., Hitkova I., Schäffer I., Lian F., Xing X., Tänzer M., Rauser S., Walch A., Feith M., et al. Bile acids down-regulate caveolin-1 in esophageal epithelial cells through sterol responsive element-binding protein. Mol. Endocrinol. 2012, 26:819-832.
30. Razani B., Combs T.P., Wang X.B., Frank P.G., Park D.S., Russell R.G., Li M., Tang B., Jelicks L.A., Scherer P.E., Lisanti M.P. Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. J.Biol. Chem. 2002, 277:8635-8647.
31. Schroeder F., Petrescu A.D., Huang H., Atshaves B.P., McIntosh A.L., Martin G.G., Hostetler H.A., Vespa A., Landrock D., Landrock K.K., et al. Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription. Lipids 2008, 43:1-17.
32. Seol W., Hanstein B., Brown M., Moore D.D. Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner). Mol. Endocrinol. 1998, 12:1551-1557.
33. Wang L., Lee Y.K., Bundman D., Han Y., Thevananther S., Kim C.S., Chua S.S., Wei P., Heyman R.A., Karin M., Moore D.D. Redundant pathways for negative feedback regulation of bile acid production. Dev. Cell 2002, 2:721-731.
34. Watanabe M., Houten S.M., Wang L., Moschetta A., Mangelsdorf D.J., Heyman R.A., Moore D.D., Auwerx J. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J.Clin. Invest. 2004, 113:1408-1418.
35. Woudenberg J., Rembacz K.P., van den Heuvel F.A., Woudenberg-Vrenken T.E., Buist-Homan M., Geuken M., Hoekstra M., Deelman L.E., Enrich C., Henning R.H., et al. Caveolin-1 is enriched in the peroxisomal membrane of rat hepatocytes. Hepatology 2010, 51:1744-1753.
36. Yang X., Downes M., Yu R.T., Bookout A.L., He W., Straume M., Mangelsdorf D.J., Evans R.M. Nuclear receptor expression links the circadian clock to metabolism. Cell 2006, 126:801-810.